Literature DB >> 4744022

Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis.

E L Quinn, D Pohlod, T Madhavan, K Burch, E Fisher, F Cox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4744022     DOI： 10.1093/infdis/128.supplement_2.s386

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  30 in total

Review 1.  Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins.

Authors:  L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

2.  Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  D J Livorsi; E Crispell; S W Satola; E M Burd; R Jerris; Y F Wang; M M Farley
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

3.  Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Authors:  Jennifer Dien Bard; Janet A Hindler; Howard S Gold; Brandi Limbago
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

4.  Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.

Authors:  Lina P Carvajal; Sandra Rincon; Aura M Echeverri; Jessica Porras; Rafael Rios; Karen M Ordoñez; Carlos Seas; Sara I Gomez-Villegas; Lorena Diaz; Cesar A Arias; Jinnethe Reyes
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

5.  Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.

Authors:  Kimberly G Blumenthal; Ilan Youngster; Erica S Shenoy; Aleena Banerji; Sandra B Nelson
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

6.  Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children.

Authors:  J Chase McNeil; Lauren M Sommer; Mary Boyle; Patrick Hogan; Jesus G Vallejo; Kristina G Hultén; Anthony R Flores; Sheldon L Kaplan; Stephanie Fritz
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.

Authors:  Sun Hee Lee; Wan Beom Park; Shinwon Lee; Sohee Park; Shin Woo Kim; Jong-Myung Lee; Hyun Ha Chang; Ki Tae Kwon; Pyoeng Gyun Choe; Nam Joong Kim; Hong Bin Kim; Myoung-Don Oh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.

Authors:  Julius Li; Kelly L Echevarria; Darrel W Hughes; Jose A Cadena; Jason E Bowling; James S Lewis
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

9.  Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients.

Authors:  A B Kaiser; M R Petracek; J W Lea; D S Kernodle; A C Roach; W C Alford; G R Burrus; D M Glassford; C S Thomas; W S Stoney
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

10.  Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.

Authors:  M Gurwith; W Albritton; B Lank; G Harding; A Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.